je.st
news
Tag: amgen
U.S. FDA approves Amgen leukemia drug ahead of schedule
2014-12-04 00:02:10| Biotech - Topix.net
U.S. health regulators on Wednesday approved an Amgen Inc drug that helps the immune system fight a rare type of leukemia, more than five months ahead of the expected decision date. The drug, blinatumomab, which will be sold under the brand name Blincyto, was approved to treat a form of acute lymphoblastic leukemia for which there are currently virtually no treatment options.
Amgen And AstraZeneca Announce Positive Results From Third And Final...
2014-11-26 10:28:14| Biotech - Topix.net
Amgen and AstraZeneca today announced that AMAGINE-2TM, a pivotal, multi-arm Phase 3 trial evaluating two doses of brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis, met its primary endpoints when compared with both StelaraA and placebo at week 12. Brodalumab 210 mg given every two weeks and the brodalumab weight-based analysis group were each shown to be superior to Stelara on the primary endpoint of achieving total clearance of skin disease, as measured by the Psoriasis Area Severity Index .
Tags: results
final
third
positive
Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3...
2014-11-05 13:20:10| Biotech - Topix.net
Amgen today announced the top-line secondary endpoint results of overall survival from the Phase 3 TRINOVA-1 trial in women with recurrent platinum-resistant ovarian cancer. The study, which evaluated trebananib plus paclitaxel versus placebo plus paclitaxel, did not demonstrate a statistically significant improvement in overall survival.
Tags: results
phase
secondary
announces
Amgen, bowing to hedge fund pressure, to cut up to 1,100 more jobs
2014-10-29 17:48:20| Biotech - Topix.net
Amgen Inc. said Tuesday it will eliminate up to 1,100 additional jobs next year as the firm faces pressure to split into two. Amgen Inc. said Tuesday it will eliminate up to 1,100 additional jobs next year as the firm faces pressure to split into two.
Amgen plans more job cuts, higher...
2014-10-28 21:54:17| Biotech - Topix.net
Amgen is expanding its plans to cut jobs next year even as it looks to stock repurchases and higher dividends to return about 60 percent of its adjusted earnings to shareholders through 2018. Its stock climbed in morning trading Tuesday.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] next »